Clinicopathologic characteristics and prognostic significance ofEGFRandp53mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension

The Significance of Visceral Pleural Surface Invasion in 321 Cases of Non-Small Cell Lung Cancers with Pleural Retraction

(2012) Yih-Leong Chang et al.   ANNALS OF SURGICAL ONCOLOGY

Clinical Significance of Thyroid Transcription Factor-1 in Advanced Lung Adenocarcinoma Under Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment

(2011) Kuei-Pin Chung et al.   CHEST

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

Comparison of p53 and Epidermal Growth Factor Receptor Gene Status Between Primary Tumors and Lymph Node Metastases in Non-Small Cell Lung Cancers

(2010) Yih-Leong Chang et al.   ANNALS OF SURGICAL ONCOLOGY

Non-BAC Component but not Epidermal Growth Factor Receptor Gene Mutation is Associated with Poor Outcomes in Small Adenocarcinoma of the Lung

(2010) Naruyuki Kobayashi et al.   Journal of Thoracic Oncology

Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma

(2010) Takayuki Kosaka et al.   Journal of Thoracic Oncology

Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma

(2008) Jenifer L. Marks et al.   Journal of Thoracic Oncology

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer

(2008) Helena Linardou et al.   LANCET ONCOLOGY